Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study

Adaani Frost, Munir Janmohamed, Jason S. Fritz, John W. McConnell, David Poch, Terry Ann Fortin, Chad E. Miller, Kelly M. Chin, Micah Fisher, Michael Eggert, Colleen McEvoy, Raymond L. Benza, Harrison W. Farber, Nick H. Kim, Thomas Pfister, Yoko Shiraga, Vallerie McLaughlin

Open source

DOI: 10.1016/j.healun.2018.09.003
Published: 2019-01
Container: The Journal of Heart and Lung Transplantation
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.healun.2018.09.003,
  title = {Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study},
  author = {Adaani Frost and Munir Janmohamed and Jason S. Fritz and John W. McConnell and David Poch and Terry Ann Fortin and Chad E. Miller and Kelly M. Chin and Micah Fisher and Michael Eggert and Colleen McEvoy and Raymond L. Benza and Harrison W. Farber and Nick H. Kim and Thomas Pfister and Yoko Shiraga and Vallerie McLaughlin},
  year = {2019},
  journal = {The Journal of Heart and Lung Transplantation},
  doi = {10.1016/j.healun.2018.09.003},
  url = {https://doi.org/10.1016/j.healun.2018.09.003}
}

RIS

TY  - JOUR
TI  - Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study
AU  - Adaani Frost
AU  - Munir Janmohamed
AU  - Jason S. Fritz
AU  - John W. McConnell
AU  - David Poch
AU  - Terry Ann Fortin
AU  - Chad E. Miller
AU  - Kelly M. Chin
AU  - Micah Fisher
AU  - Michael Eggert
AU  - Colleen McEvoy
AU  - Raymond L. Benza
AU  - Harrison W. Farber
AU  - Nick H. Kim
AU  - Thomas Pfister
AU  - Yoko Shiraga
AU  - Vallerie McLaughlin
PY  - 2019
JO  - The Journal of Heart and Lung Transplantation
DO  - 10.1016/j.healun.2018.09.003
UR  - https://doi.org/10.1016/j.healun.2018.09.003
ER  -

APA

Frost, A., Janmohamed, M., Fritz, J. S., McConnell, J. W., Poch, D., Fortin, T. A., Miller, C. E., Chin, K. M., Fisher, M., Eggert, M., McEvoy, C., Benza, R. L., Farber, H. W., Kim, N. H., Pfister, T., Shiraga, Y., & McLaughlin, V. (2019). Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study. The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2018.09.003

Source records

crossref · retrieved 2026-09-27T00:20:24.878Z